M.S., finance, Carroll School of Management, Boston College; M.A., economics, Boston University; Bachelor of Music, University of Southern Maine; CFA charterholder
Summary of Experience
Mr. Davis specializes in applying financial economics and data analysis to major litigation matters, with a focus on agricultural markets and pharmaceutical products. He has experience managing case teams, supporting academic affiliates and industry experts, and assisting clients through all phases of complex business litigation, including fact discovery, class certification, merits, trial, and settlement. Mr. Davis’s agricultural experience includes antitrust matters involving allegations of market power in animal protein markets, matters involving the presence of genetically modified products in US grain supplies, and matters involving international trade in agricultural products. His pharmaceutical work includes antitrust matters involving allegations of delayed generic entry, False Claims Act matters involving allegations related to the promotion of pharmaceuticals, and disputes pertaining to the commercial reasonableness of firm conduct.
Mr. Davis also has experience conducting economic research across a variety of industries, including financial services, agriculture, and pharmaceuticals, and analyzing issues related to commodity markets, futures prices, intellectual property and patents, industrial organization and antitrust law, and financial market infrastructure. He is a CFA charterholder.
- Daiichi Sankyo and Ranbaxy Laboratories Damages Arbitration
- Genetically Modified Rice Litigation
- In re: Lamictal Direct Purchaser Antitrust Litigation
- Surface Transportation Board: STB Ex Parte No. 664 (Sub-No. 1)
- Value Drug Company v. Takeda Pharmaceuticals USA Inc., et al.
- Veleron Holding, BV v. BNP Paribas SA et al.
- Wellbutrin XL Antitrust Litigation
Law360, July 19, 2016
Law360, August 24, 2016
FDLI Update, January/February 2013
January 18, 2023
March 15, 2023